FcαRI (CD89) alleles determine the proinflammatory potential of serum IgA

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3973-3982

  Wu, Jianming ^a   Ji, Chuanyi ^a   Xie, Fenglong ^a   Langefeld, Carl D ^b   Qian, Kun ^a   Gibson, Andrew W ^a   Edberg, Jeffrey C ^a   Kimberly, Robert P ^a  

^a The University of Alabama at Birmingham   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; FC RECEPTOR; GENOMIC DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; RNA; TUMOR NECROSIS FACTOR ALPHA; FC(ALPHA) RECEPTOR; IL6 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; ETHNIC GROUP; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKEMIA CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DEGRANULATION; ENDOCYTOSIS; GENETICS; IMMUNOLOGY; MISSENSE MUTATION; PHAGOCYTOSIS; TUMOR CELL LINE;

ALLELES; ANIMALS; ANTIGENS, CD; CELL DEGRANULATION; CELL LINE, TUMOR; ENDOCYTOSIS; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUTATION, MISSENSE; NEUTROPHILS; PHAGOCYTOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RECEPTORS, FC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947203686     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3973     Document Type: Article

References (58)

1. Stewart, W. W., and M. A. Kerr. 1990. The specificity of the human neutrophil IgA receptor (FcαR) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology 71: 328-334.
2. van Egmond, M., E. van Garderen, A. B. van Spriel, C. A. Damen, E. S. van Amersfoort, G. van Zandbergen, J. van Hattum, J. Kuiper, and J. G. van de Winkel. 2000. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6: 680-685.
3. Motegi, Y., and H. Kita. 1998. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J. Immunol. 161: 4340-4346.
4. van Egmond, M., C. A. Damen, A. B. van Spriel, G. Vidarsson, E. van Garderen, and J. G. van de Winkel. 2001. IgA and the IgA Fc receptor. Trends Immunol. 22: 205-211.
5. Kilian, M., J. Reinholdt, H. Lomholt, K. Poulsen, and E. V. Frandsen. 1996. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 104: 321-338.
6. Monteiro, R. C., and J. G. Van De Winkel. 2003. IgA Fc receptors. Annu. Rev. Immunol. 21: 177-204.
7. Fanger, M. W., L. Shen, J. Pugh, and G. M. Bernier. 1980. Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA. Proc. Natl. Acad. Sci. USA 77: 3640-3644.
8. Wende, H., M. Colonna, A. Ziegler, and A. Volz. 1999. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm. Genome 10: 154-160.
9. Wagtmann, N., S. Rojo, E. Eichler, H. Mohrenweiser, and E. O. Long. 1997. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr. Biol. 7: 615-618.
10. de Wit, T. P., H. C. Morton, P. J. Capel, and J. G. van de Winkel. 1995. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J. Immunol. 155: 1203-1209.
11. van Dijk, T. B., M. Bracke, E, Caldenhoven, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and R. P. de Groot. 1996. Cloning and characterization of FcαRb, a novel Fcα receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood 88: 4229-4238.
12. Morton, H. C., A. E. Schiel, S. W. Janssen, and J. G. van de Winkel. 1996. Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils. Immunogenetics 43: 246-247.
13. Reterink, T. J., C. L. Verweij, L. A. van Es, and M. R. Daha. 1996. Alternative splicing of IgA Fc receptor (CD89) transcripts. Gene 175: 279-280.
14. Pleass, R. J., P. D. Andrews, M. A. Kerr, and J. M. Woof. 1996. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem. J. 318: 771-777.
15. Toyabe, S., Y. Kuwano, K. Takeda, M. Uchiyama, and T. Abo. 1997. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells. Clin. Exp. Immunol. 110: 226-232.
16. Togo, S., T. Shimokawa, Y. Fukuchi, and C. Ra. 2003. Alternative splicing of myeloid IgA Fc receptor (FcαR, CD89) transcripts in inflammatory responses. FEBS Lett. 535: 205-209.
17. Patry, C., Y. Sibille, A. Lehuen, and R. C. Monteiro. 1996. Identification of Fcα receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 156: 4442-4448.
18. Sondermann, P., R. Huber, V. Oosthuizen, and U. Jacob. 2000. The 3.2-A crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406: 267-273.
19. Garman, S. C., B. A. Wurzburg, S. S. Tarchevskaya, J. P. Kinet, and T. S. Jardetzky. 2000. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRI α. Nature 406: 259-266.
20. Wines, B. D., M. D. Hulett, G. P. Jamieson, H. M. Trist, J. M. Spratt, and P. M. Hogarth. 1999. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA. J. Immunol. 162: 2146-2153.
21. Morton, H. C., G. van Zandbergen, C. van Kooten, C. J. Howard, J. G. van de Winkel, and P. Brandtzaeg. 1999. Immunoglobulin-binding sites of human FcγRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains. J. Exp. Med. 189: 1715-1722.
22. Pleass, R. J., J. I. Dunlop, C. M. Anderson, and J. M. Woof. 1999. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcα receptor (FcαR) CD89. J. Biol. Chem. 274: 23508-23514.
23. Carayannopoulos, L., J. M. Hexham, and J. D. Capra. 1996. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J. Exp. Med. 183: 1579-1586.
24. Herr, A. B., E. R. Ballister, and P. J. Bjorkman. 2003. Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 423: 614-620.
25. Herr, A. B., C. L. White, C. Milburn, C. Wu, and P. J. Bjorkman. 2003. Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 327: 645-657.
26. Launay, P., C. Patry, A. Lehuen, B. Pasquier, U. Blank, and R. C. Monteiro. 1999. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J. Biol. Chem. 274: 7216-7225.
27. Honorio-Franca, A. C., P. Launay, M. M. Carneiro-Sampaio, and R. C. Monteiro. 2001. Colostral neutrophils express Fcα receptors (CD89) lacking γ chain association and mediate noninflammatory properties of secretory IgA. J. Leukocyte Biol. 69: 289-296.
28. Launay, P., A. Lehuen, T. Kawakami, U. Blank, and R. C. Monteiro. 1998. IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-γ or phorbol ester stimulation. J. Leukocyte Biol. 63: 636-642.
29. Lang, M. L., Y. W. Chen, L. Shen, H. Gao, G. A. Lang, T. K. Wade, and W. F. Wade. 2002. IgA Fc receptor (FcαR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem. J. 364: 517-525.
30. Morton, H. C., I. E. van den Herik-Oudijk, P. Vossebeld, A. Snijders, A. J. Verhoeven, P. J. Capel, and J. G. van de Winkel. 1995. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ chain: molecular basis for CD89/FcR γ chain association. J. Biol. Chem. 270: 29781-29787.
31. Van Epps, D. E., and S. L. Brown. 1981. Inhibition of formylmethionyl-leucylphenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins. Infect. Immun. 34: 864-870.
32. Van Epps, D. E., and R. C. Williams, Jr. 1976. Suppression of leukocyte chemotaxis by human IgA myeloma components. J. Exp. Med. 144: 1227-1242.
33. Wolf, H. M., M. B. Fischer, H. Puhringer, A. Samstag, E. Vogel, and M. M. Eibl. 1994. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-α, interleukin-6) in human monocytes. Blood 83: 1278-1288.
34. Wolf, H. M., I. Hauber, H. Gulle, A. Samstag, M. B. Fischer, R. U. Ahmad, and M. M. Eibl. 1996. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and FcαR (CD89)-mediated down-regulation of tumour necrosis factor-α (TNF-α) and IL-6 in human monocytes. Clin. Exp. Immunol. 105: 537-543.
35. Wolf, H. M., E. Vogel, M. B. Fischer, H. Rengs, H. P. Schwarz, and M. M. Eibl. 1994. Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Pediatr. Res. 36: 235-243.
36. Pasquier, B., P. Launay, Y. Kanamaru, I. C. Moura, S. Pfirsch, C. Ruffie, D. Henin, M. Benhamou, M. Pretolani, U. Blank, and R. C. Monteiro. 2005. Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 22: 31-42.
37. Wu, J., J. C. Edberg, P. B. Redecha, V. Bansal, P. M. Guyre, K. Coleman, J. E. Salmon, and R. P. Kimberly. 1997. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100: 1059-1070.
38. Li, X., J. Wu, R. H. Carter, J. C. Edberg, K. Su, G. S. Cooper, and R. P. Kimberly. 2003. A novel polymorphism in the Fey receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48: 3242-3252.
39. Jasek, M., M. Manczak, A. Sawaryn, A. Obojski, A. Wisniewski, W. Luszczek, and P. Kusnierczyk. 2004. A novel polymorphism in the cytoplasmic region of the human immunoglobulin A Fc receptor gene. Eur. J. Immunogenet. 31: 59-62.
40. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, I. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
41. Pfefferkorn, L. C., and G. R. Yeaman. 1994. Association of IgA-Fc receptors (FcαR) with FcεRIγ 2 subunits in U937 cells: aggregation induces the tyrosine phosphorylation of γ 2. J. Immunol. 153: 3228-3236.
42. Morton, H. C., M. van Egmond, and J. G. van de Winkel. 1996. Structure and function of human IgA Fc receptors (FcαR). Crit. Rev. Immunol. 16: 423-440.
43. Hou, X., J. Dietrich, and N. O. Geisler. 1996. The cytoplasmic tail of FcγRIIIAα is involved in signaling by the low affinity receptor for immunoglobulin G. J. Biol. Chem. 271: 22815-22822.
44. Guile, H., A. Samstag, M. M. Eibl, and H. M. Wolf. 1998. Physical and functional association of FcαR with protein tyrosine kinase Lyn. Blood 91: 383-391.
45. Cucurull, E., A. E. Gharavi, E. Diri, E. Mendez, D. Kapoor, and L. R. Espinoza. 1999. IgA anticardiolipin and anti-β2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am. J. Med. Sci. 318: 55-60.
46. Chen, C. J., K. H. Lin, S. C. Lin, W. C. Tsai, J. H. Yen, S. J. Chang, S. N. Lu, and H. W. Liu. 2005. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J. Rheumatol. 32: 44-47.
47. Barnett, P., G. Bottger, A. T. Klein, H. F. Tabak, and B. Distel. 2000. The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction. EMBO J. 19: 6382-6391.
48. Bottger, G., P. Barnett, A. T. Klein, A. Kragt, H. F. Tabak, and B. Distel. 2000. Saccharomyces cerevisiae PTS1 receptor Pex5p interacts with the SH3 domain of the peroxisomal membrane protein Pex13p in an unconventional, non-PXXP-related manner. Mol. Biol. Cell 11: 3963-3976.
49. Schliebs, W., I. Saidowsky, B. Agianian, G. Dodt, F. W. Herberg, and W. H. Kunau. 1999. Recombinant human peroxisomal targeting signal receptor PEX5: structural basis for interaction of PEX5 with PEX14. J. Biol. Chem. 274: 5666-5673.
50. Conley, M. E., and W. J. Koopman. 1983. Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease. Clin. Immunol. Immunopathol. 26: 390-397.
51. Diri, E., E. Cucurull, A. E. Gharavi, D. Kapoor, E. A. Mendez, E. Scopelitis, and W. A. Wilson. 1999. Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and aβ2 glycoprotein-I is the most frequent isotype. Lupus 8: 263-268.
52. Greco, T. P., M. D. Amos, A. M. Conti-Kelly, J. D. Naranjo, and J. W. Ijdo. 2000. Testing for the antiphospholipid syndrome: importance of IgA anti-β2-glycoprotein I. Lupus 9: 33-41.
53. Parks, C. G., G. S. Cooper, L. L. Hudson, M. A. Dooley, E. L. Treadwell, E. W. St Clair, G. S. Gilkeson, and J. P. Pandey. 2005. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum. 52: 1148-1159.
54. Huang, Y. T., A. Wright, X. Gao, L. Kulick, H. Yan, and M. E. Lamm. 2005. Intraepithelial cell neutralization of HIV-1 replication by IgA. J. Immunol. 174: 4828-4835.
55. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R γ null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174: 6477-6489.
56. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J. C. Piffaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
57. Conley, M. E., and D. L. Delacroix. 1987. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann. Intern. Med. 106: 892-899.
58. Olas, K., H. Butterweck, W. Teschner, H. P. Schwarz, and B. Reipert. 2005. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin. Exp. Immunol. 140: 478-490.